arrow_back Trending Legislation
Share share

PrEP Assistance Program: Free Access to HIV Prevention Medication

This act establishes a grant program for states, tribal governments, health centers, and local organizations to offer HIV prevention (PrEP) programs. This means citizens at risk of HIV infection can receive medication and related services free of charge, improving access to preventive healthcare.
Key points
Free Access to PrEP Medication and Testing: Individuals participating in PrEP programs will not be required to pay for medication, doctor visits, blood and urine tests, or STD screenings.
Support for Local Communities: Grants will help states, tribal governments, local authorities, and community organizations establish or expand PrEP programs, increasing access to prevention in various regions.
Funding and Oversight: The program is authorized for $400 million annually for five years, and the Secretary of Health will regularly report to Congress on its impact.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
PrEP Assistance Program Act
Print number: HR 5605
Sponsor: Rep. Watson Coleman, Bonnie [D-NJ-12]
Process start date: 2021-10-15
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about PrEP Assistance Program: Free Access to HIV Prevention Medication

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5605.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-10-15.

What are the main provisions?

Key points include:

  • Free Access to PrEP Medication and Testing: Individuals participating in PrEP programs will not be required to pay for medication, doctor visits, blood and urine tests, or STD screenings.
  • Support for Local Communities: Grants will help states, tribal governments, local authorities, and community organizations establish or expand PrEP programs, increasing access to prevention in various regions.
  • Funding and Oversight: The program is authorized for $400 million annually for five years, and the Secretary of Health will regularly report to Congress on its impact.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Watson Coleman, Bonnie [D-NJ-12].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

Analysis and Potential Impact of HR 5605

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health